News

TASP1-mediated cleavage of REV3L enhances the activity of DNA polymerase ζ in mammalian cells

The Kannouche team contributed to this study, published in Cancer Cell (2026), reporting the results of the ICARUS-LUNG01 Phase II trial: Efficacy, Safety, and Biomarker Analysis of Datopotamab Deruxtecan in Advanced Non-Small Cell Lung Cancer. The study evaluates the clinical activity, safety profile, and predictive biomarkers associated with datopotamab deruxtecan in patients with advanced non-small cell lung cancer.

Read More

Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study

The Kannouche team contributed to this study, published in Cancer Cell (2026), reporting the results of the ICARUS-LUNG01 Phase II trial: Efficacy, Safety, and Biomarker Analysis of Datopotamab Deruxtecan in Advanced Non-Small Cell Lung Cancer. The study evaluates the clinical activity, safety profile, and predictive biomarkers associated with datopotamab deruxtecan in patients with advanced non-small cell lung cancer.

Read More

16th 3R meeting

16th edition of the French 3R meeting “Replication, Recombination, Repair” We are happy to announce the opening of registrations for the 16th

Read More

Next Unit Lab Meeting

Prochaine réunion d’unité

13/10/2025
Salle Roger Monier 13h30
Speaker: Nataliya PETRYK

“  Revealing the mechanisms linking genome replication and epigenome maintenance « 

Read More